MET1A antibody refers to therapeutic or research-grade monoclonal antibodies targeting the MET receptor tyrosine kinase, a proto-oncogene critical for cancer progression. While the term "MET1A" is not standardized in literature, it likely denotes antibodies against MET (mesenchymal-epithelial transition factor), a high-affinity receptor for hepatocyte growth factor (HGF). MET drives invasive growth, metastasis, and therapeutic resistance in cancers like non-small-cell lung cancer (NSCLC) .
Anti-MET antibodies disrupt MET signaling through:
Ligand blockade: Preventing HGF binding to MET’s extracellular domain .
Receptor internalization: Inducing MET clustering and degradation (e.g., ARGX-111) .
Bispecific targeting: Dual engagement of MET and other receptors (e.g., EGFR/MET bispecific antibody amivantamab) .
Antibody-drug conjugates (ADCs): Delivering cytotoxic payloads to MET-overexpressing cells (e.g., telisotuzumab vedotin) .
Amivantamab demonstrated a 44% objective response rate (ORR) in HER2-mutant NSCLC, with median progression-free survival (mPFS) of 6 months .
ABBV-400 showed a 15% ORR in low c-MET tumors and 30% in high c-MET tumors at doses ≥2.4 mg/kg .
MET amplification: Observed in 5–20% of EGFR-mutant NSCLC post-TKI therapy .
Dysregulated downstream pathways: Activation of RAS-MAPK or PI3K-AKT despite MET inhibition .
Biomarkers: MET overexpression (IHC), MET exon 14 skipping mutations, and MET amplification predict response .
MET clustering: Anti-MET antibodies induce polarized receptor clusters on the plasma membrane, accelerating internalization and degradation .
MAT1A interaction: Methionine adenosyltransferase 1A (MAT1A) overexpression correlates with chemoresistance in bladder cancer, though unrelated to MET signaling .
Combination therapies: Pairing MET antibodies with TKIs or immune checkpoint inhibitors to overcome resistance .
Novel ADCs: Optimizing payloads (e.g., topoisomerase inhibitors) to enhance tumor specificity .
Biomarker refinement: Developing liquid biopsies for real-time MET amplification monitoring .
MET1A is a DNA methyltransferase protein found in Oryza sativa subsp. japonica (Rice) and other plant species. It plays a crucial role in maintaining CpG methylation patterns during DNA replication. The protein is encoded by the LOC4334435 gene in rice and functions primarily in epigenetic regulation processes . Unlike the mammalian protein MATα1 (Methionine adenosyltransferase α1), which is involved in S-adenosylmethionine biosynthesis , plant MET1A is specifically involved in DNA methylation maintenance.
The biological significance of MET1A lies in its essential role in maintaining genomic stability, regulating gene expression, and protecting the genome from transposable elements. Research has shown that alterations in MET1A expression can lead to significant changes in methylation patterns, potentially affecting plant development and stress responses.
MET1A antibody has several important applications in plant research:
Western Blotting (WB): For detecting and quantifying MET1A protein levels in plant tissue extracts
Enzyme-Linked Immunosorbent Assay (ELISA): For sensitive quantification of MET1A in complex biological samples
Chromatin Immunoprecipitation (ChIP): For identifying genomic regions associated with MET1A binding
Immunohistochemistry: For visualizing the cellular and subcellular localization of MET1A in plant tissues
Protein interaction studies: For investigating protein complexes involving MET1A
These applications enable researchers to study MET1A's role in various biological processes, including developmental transitions, environmental responses, and epigenetic regulation mechanisms.
When selecting a MET1A antibody, consider the following factors:
Antibody type: Polyclonal antibodies like the one described in the search results offer good sensitivity but may have batch-to-batch variation. Monoclonal antibodies provide higher specificity and consistency .
Species reactivity: Ensure the antibody recognizes MET1A from your species of interest. The antibody discussed is specific for rice MET1A .
Applications: Verify that the antibody has been validated for your intended application (WB, ELISA, etc.) .
Immunogen information: Understanding the immunogen used to generate the antibody helps predict epitope recognition. The antibody described uses recombinant Oryza sativa MET1A protein as the immunogen .
Validation data: Request validation data showing the antibody's specificity and sensitivity in applications similar to your planned experiments.
For optimal Western blot results with MET1A antibody, follow these guidelines:
Sample preparation:
Extract proteins using a buffer containing protease inhibitors
Heat samples at 95°C for 5 minutes in reducing SDS buffer
Load 20-50 μg of total protein per lane
Electrophoresis and transfer:
Use 8-10% SDS-PAGE gels (MET1A is a large protein)
Transfer to PVDF membrane at 25V overnight at 4°C
Blocking and antibody incubation:
Detection:
Use HRP-conjugated secondary antibody specific to rabbit IgG
Develop using enhanced chemiluminescence (ECL) substrate
Controls:
Always include the provided recombinant immunogen protein as a positive control
Use the pre-immune serum to identify non-specific binding
For optimal ELISA results with MET1A antibody:
Coating parameters:
Use carbonate/bicarbonate buffer (pH 9.6) for coating
Coat plates with 1-10 μg/ml of capture antibody or antigen
Incubate overnight at 4°C
Blocking:
Block with 1-3% BSA or 5% non-fat milk in PBS
Block for 1-2 hours at room temperature
Sample preparation:
Antibody dilution:
Titrate antibody concentrations (typically starting at 1:1000)
Incubate for 1-2 hours at room temperature
Detection optimization:
Use appropriate enzyme-conjugated secondary antibody
Optimize substrate incubation time (usually 15-30 minutes)
Read at appropriate wavelength
Troubleshooting:
High background: Increase blocking time or use different blocking agent
Low signal: Increase antibody concentration or sample loading
Non-specific binding: Include 0.05% Tween-20 in wash buffers
Including appropriate controls is critical for validating results with MET1A antibody:
Essential controls:
Positive control: Use the recombinant immunogen protein provided with the antibody package
Negative control: Include pre-immune serum to identify non-specific binding
No primary antibody control: Include samples where only secondary antibody is applied
Knockdown/knockout validation: Where possible, include samples from MET1A-deficient plants
Competing peptide control: Pre-incubate antibody with excess recombinant MET1A protein to confirm specificity
Analysis controls:
Loading control: Use antibodies against housekeeping proteins (e.g., actin, tubulin) to normalize protein loading
Tissue-specific controls: Include tissues known to have high and low MET1A expression
Cross-reactivity controls: Test the antibody against related methyltransferases to assess specificity
MET1A likely forms complexes with other proteins involved in DNA methylation and chromatin remodeling. To study these interactions:
Co-immunoprecipitation (Co-IP):
Lyse plant cells in non-denaturing buffer
Incubate lysate with MET1A antibody
Capture antibody-protein complexes with Protein A/G beads
Analyze co-precipitated proteins by Western blot or mass spectrometry
This approach can be informed by studies of other methyltransferases. For example, studies of MATα1 (a different methyltransferase) revealed interactions with mitochondrial proteins through co-IP followed by mass spectrometry analysis .
Proximity ligation assay (PLA):
Fix and permeabilize plant tissues
Incubate with MET1A antibody and antibody against candidate interacting protein
Use PLA probes and detection reagents to visualize interactions in situ
Bimolecular Fluorescence Complementation (BiFC):
Generate fusion constructs of MET1A and candidate interacting proteins with split fluorescent protein fragments
Co-express in plant cells
Analyze fluorescence complementation by microscopy
Pull-down assays with recombinant proteins:
Express recombinant MET1A with an affinity tag
Incubate with plant extracts
Capture complexes using affinity resin
Identify interacting partners by mass spectrometry
Interpreting changes in MET1A protein levels requires careful analysis:
Quantification approach:
Biological context interpretation:
Compare MET1A levels across developmental stages or stress conditions
Correlate MET1A protein changes with changes in DNA methylation patterns
Consider post-translational modifications that might affect antibody recognition
Statistical analysis:
Apply appropriate statistical tests (t-test, ANOVA) to determine significance
Use multiple biological replicates (minimum n=3)
Calculate confidence intervals for quantitative measurements
Integration with other data:
Correlate protein levels with transcript levels
Analyze in context of global methylation changes
Consider functional consequences of MET1A changes
Taking lessons from studies of other methyltransferases like MATα1, consider that changes in methyltransferase levels can have downstream effects on multiple cellular processes. For instance, changes in MATα1 levels affect mitochondrial function and influence protein methylation patterns .
Studying MET1A localization presents several challenges:
Fixation and permeabilization:
Plant cell walls require specialized fixation protocols
Optimize fixation to preserve epitope accessibility while maintaining cellular structure
Test different fixatives (4% paraformaldehyde, ethanol:acetic acid)
Antibody penetration:
Plant cell walls can hinder antibody penetration
Use enzymatic digestion (cellulase, macerozyme) to facilitate access
Optimize incubation times and temperatures
Autofluorescence:
Plant tissues exhibit significant autofluorescence
Use appropriate filters and spectral unmixing
Consider alternative detection methods (DAB, alkaline phosphatase)
Nuclear localization visualization:
MET1A is expected to localize primarily to the nucleus
Use nuclear markers (DAPI) for co-localization
Consider confocal microscopy for improved resolution
Drawing parallels from studies of MATα1, which was found to localize to both the cytosol and mitochondria using immunogold electron microscopy , similar advanced techniques might be needed to accurately determine MET1A subcellular distribution.
When faced with weak or absent signals:
| Problem | Possible Causes | Solutions |
|---|---|---|
| No signal in Western blot | Insufficient protein | Increase protein loading (40-60 μg) |
| Inefficient transfer | Check transfer efficiency with stained markers | |
| Degraded antibody | Use fresh aliquot, verify storage conditions | |
| Inappropriate detection method | Try more sensitive detection reagents | |
| Epitope denaturation | Try native conditions or different lysis buffer | |
| Weak signal in ELISA | Low antibody concentration | Increase primary antibody concentration |
| Insufficient antigen | Increase coating concentration | |
| Suboptimal blocking | Test different blocking agents (BSA, milk) | |
| Detection system issues | Use amplification systems (biotin-streptavidin) | |
| No signal in immunofluorescence | Fixation issues | Test different fixation methods |
| Insufficient permeabilization | Optimize detergent concentration and time | |
| Low protein expression | Use signal amplification methods | |
| Epitope masking | Try antigen retrieval methods |
Non-specific binding can complicate data interpretation. Address this issue by:
Optimizing blocking conditions:
Test different blocking agents (BSA, normal serum, milk)
Increase blocking time or concentration
Add 0.1-0.3% Triton X-100 or Tween-20 to reduce hydrophobic interactions
Antibody dilution optimization:
Perform titration experiments to determine optimal concentration
Generally, higher dilutions reduce non-specific binding
Pre-absorption controls:
Alternative secondary antibodies:
Test different sources or formats of secondary antibodies
Consider highly cross-adsorbed secondary antibodies
Additional washes:
Increase number and duration of wash steps
Use higher salt concentration in wash buffers
Validation with pre-immune serum:
When expanding MET1A research to new plant species:
Sequence homology analysis:
Compare MET1A sequence between reference species (rice) and target species
Focus on the immunogen region used to generate the antibody
Predict cross-reactivity based on epitope conservation
Western blot validation:
Run samples from both species side by side
Verify expected molecular weight differences
Look for single, specific band at predicted size
Immunoprecipitation-mass spectrometry:
Perform IP with MET1A antibody using extracts from the new species
Identify precipitated proteins by mass spectrometry
Confirm MET1A identity through peptide matching
Genetic approach validation:
If available, use MET1A mutants or knockdown lines
Compare antibody signal between wild-type and mutant samples
Expect reduced or absent signal in mutants
Competing peptide approach:
Pre-incubate antibody with synthesized peptides from the new species' MET1A
Demonstrate signal reduction with specific peptide
Understanding MET1A in the context of other methyltransferases provides valuable research insights:
Functional comparison with mammalian DNA methyltransferases:
Unlike DNMT1 in mammals, plant MET1A may have broader substrate specificity
Both maintain CpG methylation but may differ in regulatory mechanisms
MET1A lacks the RFTS domain found in mammalian DNMT1
Comparison with other plant methyltransferases:
MET1A works alongside other methyltransferases (CMT3, DRM2) in plants
Different methyltransferase families maintain distinct methylation contexts (CpG, CHG, CHH)
Coordination between these enzymes ensures proper epigenetic regulation
Evolutionary conservation analysis:
MET1A structure is conserved across plant species but with species-specific adaptations
Functional domains show different levels of conservation
Catalytic domains typically show highest conservation
Interesting parallels can be drawn to studies of MATα1, which showed that this methyltransferase has multiple cellular functions beyond its canonical role, including protein-protein interactions that affect mitochondrial function .
To study developmental methylation changes:
Developmental time course experiments:
Collect tissues at different developmental stages
Quantify MET1A protein levels by Western blot or ELISA
Correlate with global DNA methylation measurements
Tissue-specific analysis:
Compare MET1A levels across different plant tissues
Use immunohistochemistry to visualize tissue-specific distribution
Correlate with tissue-specific methylation patterns
Stress response studies:
Expose plants to various stressors
Monitor changes in MET1A protein levels and localization
Connect to methylation changes at specific loci
Integration with genomic approaches:
Combine ChIP using MET1A antibody with sequencing (ChIP-seq)
Identify genomic regions bound by MET1A
Correlate with whole-genome bisulfite sequencing data
Similar to how MATα1 deficiency affects cellular functions through altered methylation patterns , changes in MET1A levels likely influence plant development through epigenetic regulation of key genes.
Emerging techniques offer new possibilities for MET1A research:
Super-resolution microscopy:
Techniques like STORM, PALM, or SIM provide nanoscale resolution
Enable visualization of MET1A distribution within nuclear subdomains
Allow co-localization studies with chromatin marks at unprecedented resolution
Antibody engineering approaches:
Development of recombinant antibody fragments for improved tissue penetration
Single-domain antibodies with enhanced specificity
Biparatopic antibody designs that recognize multiple epitopes on MET1A
Proximity-dependent labeling:
Fusion of MET1A antibody with enzymes like BioID or APEX2
Identification of proteins in close proximity to MET1A in vivo
Mapping of the MET1A interactome in different cellular contexts
CRISPR-based techniques:
CRISPR-tagged endogenous MET1A for live imaging
CUT&RUN or CUT&Tag approaches using MET1A antibody
Combination with epigenetic editing to study causal relationships
Drawing from advances in other fields, techniques like those used to study MET trafficking (such as the biparatopic antibody approach ) could potentially be adapted for studying MET1A dynamics and interactions.
Post-translational modifications (PTMs) can significantly impact antibody recognition:
Common PTMs affecting antibody binding:
Phosphorylation of serine, threonine, or tyrosine residues
Methylation of lysine or arginine residues
Acetylation of lysine residues
Ubiquitination or SUMOylation
Effects on epitope recognition:
PTMs may block antibody access to epitopes
Conformational changes induced by PTMs can expose or hide epitopes
Some antibodies specifically recognize modified forms
Strategies to address PTM interference:
Use phosphatase treatment to remove phosphorylation
Generate modification-specific antibodies for comprehensive analysis
Compare results from multiple antibodies targeting different epitopes
Analytical approaches:
Mass spectrometry to identify PTMs on MET1A
2D gel electrophoresis to separate differently modified forms
Phos-tag gels to separate phosphorylated forms
Studies of other methyltransferases like MATα1 have shown that post-translational modifications can regulate their activity and interactions , suggesting similar regulatory mechanisms might exist for MET1A.